RPG Life Sciences Limited (NSE:RPGLIFE)
India · Delayed Price · Currency is INR 2,135.70
-80.50 (-3.63%)
Jan 23, 2026, 3:30 PM IST
RPG Life Sciences Revenue
RPG Life Sciences had revenue of 1.82B INR in the quarter ending September 30, 2025, with 5.50% growth. This brings the company's revenue in the last twelve months to 6.66B, up 7.78% year-over-year. In the fiscal year ending March 31, 2025, RPG Life Sciences had annual revenue of 6.53B with 12.26% growth.
Revenue (ttm)
6.66B
Revenue Growth
+7.78%
P/S Ratio
5.30
Revenue / Employee
5.01M
Employees
1,331
Market Cap
35.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.53B | 713.80M | 12.26% |
| Mar 31, 2024 | 5.82B | 692.40M | 13.50% |
| Mar 31, 2023 | 5.13B | 726.50M | 16.51% |
| Mar 31, 2022 | 4.40B | 510.20M | 13.11% |
| Mar 31, 2021 | 3.89B | 135.70M | 3.61% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 46.85B |
| Akums Drugs and Pharmaceuticals | 41.10B |
| Alivus Life Sciences | 24.81B |
| Aarti Pharmalabs | 19.06B |
| Indoco Remedies | 17.25B |
| Innova Captab | 13.63B |
| Solara Active Pharma Sciences | 12.06B |
| Windlas Biotech | 8.30B |
RPG Life Sciences News
- 3 months ago - RPG Life Sciences Ltd (BOM:532983) Q2 2026 Earnings Call Highlights: Strong Domestic Growth and ... - GuruFocus
- 3 months ago - Q2 2026 RPG Life Sciences Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - RPG Life Sciences drops nearly 6% following Q1 results - Business Upturn
- 9 months ago - RPG Life Sciences shares surge nearly 8% after Q4 net profit jumps 786% on one-time land gain - Business Upturn
- 1 year ago - RPG Life Sciences surges 9.36% on robust Q3 FY25 earnings; net profit up 32% YoY - Business Upturn
- 1 year ago - Stocks in focus today, January 27, 2025: JK Cement, Balkrishna Industries, Shakti Pumps, Yes Bank, KEC International, Trident, RPG Life Sciences, Jubilant Pharmova - Business Upturn
- 1 year ago - RPG Life Sciences reports fire incident at manufacturing plant in Navi Mumbai - Business Upturn